Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

5 Per­for­mance pil­lars that sep­a­rate strate­gic part­ners from stan­dard providers

In an era de­fined by geopo­lit­i­cal un­cer­tain­ty, cli­mate dis­rup­tion, and the re­lent­less pace of phar­ma­ceu­ti­cal in­no­va­tion, the mar­gin for er­ror in drug stor­age and dis­tri­b­u­tion has nev­er been nar­row­er. Imag­ine a life-sav­ing vac­cine, metic­u­lous­ly craft­ed and rig­or­ous­ly test­ed, ren­dered in­ef­fec­tive by a fleet­ing tem­per­a­ture ex­cur­sion dur­ing tran­sit – or a vi­tal gene ther­a­py strand­ed by a sud­den bor­der clo­sure. These are no longer hy­po­thet­i­cal risks but dai­ly re­al­i­ties for the glob­al phar­ma­ceu­ti­cal sup­ply chain.

The stakes are high: the bio­phar­ma in­dus­try los­es an es­ti­mat­ed $35 bil­lion an­nu­al­ly to tem­per­a­ture-con­trol fail­ures, with at least 20% of tem­per­a­ture-sen­si­tive prod­ucts sus­tain­ing dam­age in tran­sit. As the de­mand for ad­vanced bi­o­log­ics, per­son­al­ized ther­a­pies and di­rect-to-pa­tient mod­els ac­cel­er­ates, the ques­tion is not if your sup­ply chain will be test­ed, but when.

Pre­ci­sion lo­gis­tics, stor­age & dis­tri­b­u­tion providers are no longer just ven­dors — they are crit­i­cal part­ners in en­sur­ing pa­tient safe­ty, prod­uct in­tegri­ty and reg­u­la­to­ry com­pli­ance.

Here are five key ar­eas that sep­a­rate sup­ply chain ex­perts from every­one else:

1. Chain of cus­tody & tem­per­a­ture in­tegri­ty

Tem­per­a­ture con­trol is the foun­da­tion of phar­ma­ceu­ti­cal lo­gis­tics, par­tic­u­lar­ly for high-val­ue, tem­per­a­ture-sen­si­tive prod­ucts such as vac­cines, bi­o­log­ics, and cell and gene ther­a­pies. These prod­ucts de­mand rig­or­ous­ly con­trolled con­di­tions at every stage, from man­u­fac­tur­ing through last-mile de­liv­ery. Lead­ing providers de­ploy val­i­dat­ed mon­i­tor­ing that of­fer re­al-time vis­i­bil­i­ty in­to each ship­ment’s tem­per­a­ture, lo­ca­tion and se­cu­ri­ty sta­tus.

At Marken, we de­ploy a full suite of pre­ci­sion mon­i­tor­ing tools, in­clud­ing val­i­dat­ed da­ta log­gers, IoT sen­sors, GPS track­ing, blockchain tech­nol­o­gy and in­te­grat­ed dig­i­tal plat­forms to en­sure con­tin­u­ous over­sight of tem­per­a­ture, hu­mid­i­ty, light, shock and vi­bra­tion. As re­al-time vis­i­bil­i­ty be­comes an in­dus­try stan­dard, this lev­el of pre­cise over­sight en­ables proac­tive in­ter­ven­tion, ver­i­fies prod­uct au­then­tic­i­ty, de­liv­ers live da­ta-dri­ven in­sights and pro­tects against tem­per­a­ture ex­cur­sion, di­ver­sion or fraud. This shift to­ward prod­uct lev­el vis­i­bil­i­ty comes at a crit­i­cal time, as ad­vanced ther­a­pies, such as cell and gene treat­ments and ra­dio­phar­ma­ceu­ti­cals, move rapid­ly in­to main­stream adop­tion.

Com­bined with ad­vanced pack­ag­ing so­lu­tions, lane map­ping and ver­i­fi­ca­tion, risk man­age­ment and equip­ment val­i­da­tion, we de­liv­er both pas­sive and ac­tive pro­tec­tion un­der even the most chal­leng­ing con­di­tions — main­tain­ing an un­in­ter­rupt­ed, au­ditable chain of cus­tody from ori­gin to des­ti­na­tion.

2. Sus­tain­able stor­age and dis­tri­b­u­tion in­fra­struc­ture

Pre­ci­sion lo­gis­tics must be both glob­al, in­te­grat­ed and con­sis­tent. Frag­ment­ed ven­dor net­works in­tro­duce in­con­sis­ten­cy, in­crease lead times, and el­e­vate risk — ul­ti­mate­ly threat­en­ing pa­tient out­comes. Strate­gic part­ners elim­i­nate these vul­ner­a­bil­i­ties by of­fer­ing an en­ter­prise-wide in­fra­struc­ture that uni­fies drug sup­ply, stor­age, dis­tri­b­u­tion, and pa­tient ac­cess un­der one har­mo­nized net­work.

Marken’s ex­ten­sive glob­al net­work has syn­chro­nized SOPs, re­dun­dant con­di­tion­ing ca­pac­i­ty and ded­i­cat­ed teams man­ag­ing both com­mer­cial and clin­i­cal sup­ply. Whether it’s stor­ing in­ves­ti­ga­tion­al prod­ucts, over­see­ing de­pot-to-site dis­tri­b­u­tion, or ex­e­cut­ing di­rect-to-pa­tient de­liv­er­ies, Marken en­sures op­er­a­tional con­sis­ten­cy and mea­sur­able per­for­mance at every step.

No longer a val­ue-add, but now an ex­pec­ta­tion, sus­tain­abil­i­ty is emerg­ing as a com­pet­i­tive dif­fer­en­tia­tor. Marken in­te­grates eco-friend­ly pack­ag­ing, biodegrad­able ma­te­ri­als, and en­er­gy-ef­fi­cient trans­porta­tion and stor­age in­to its lo­gis­tics so­lu­tions, low­er­ing our en­vi­ron­men­tal im­pact and sup­port­ing clients meet en­vi­ron­men­tal goals, with­out sac­ri­fic­ing per­for­mance.

3. Reg­u­la­to­ry ex­per­tise & qual­i­ty as­sur­ance

Through­out the sup­ply chain, com­pli­ance isn’t op­tion­al, it’s es­sen­tial. A trust­ed pre­ci­sion lo­gis­tics part­ner must op­er­ate with­in the high­est stan­dards of Good Man­u­fac­tur­ing Prac­tices (GMP) and Good Dis­tri­b­u­tion Prac­tices (GDP) stan­dards to en­sure qual­i­ty, safe­ty and full reg­u­la­to­ry align­ment at every step. This isn’t just about meet­ing re­quire­ments; it’s about build­ing trust with man­u­fac­tur­ers, reg­u­la­tors and pa­tients alike.

As drug modal­i­ties be­come more com­plex and reg­u­la­tions in­ten­si­fy across glob­al mar­kets, ex­pe­ri­enced part­ners bring the reg­u­la­to­ry in­sight and op­er­a­tional ex­per­tise need­ed to nav­i­gate an evolv­ing, mul­ti-ju­ris­dic­tion­al land­scape. En­sur­ing drug in­tegri­ty de­mands not on­ly rig­or­ous en­vi­ron­men­tal con­trols but a shared ded­i­ca­tion to the same high stan­dards as the man­u­fac­tur­ers them­selves.

Marken’s glob­al op­er­a­tions are built on har­mo­nized qual­i­ty sys­tems, and our reg­u­la­to­ry and trade com­pli­ance teams work proac­tive­ly with spon­sors to align with lo­cal and in­ter­na­tion­al au­thor­i­ties. This com­mit­ment en­sures seam­less de­liv­ery, mit­i­gates risk, and pro­tects both time­lines and pa­tient out­comes.

4. Op­er­a­tional re­silience un­der pres­sure

Over the past five years, the glob­al sup­ply chain has en­dured a re­lent­less se­ries of stress tests – from pan­demics and cli­mate dis­as­ters to la­bor short­ages and geopo­lit­i­cal up­heaval. Now, in 2025, the land­scape grows even more com­plex as shift­ing US pol­i­cy up­ends sup­ply chains and hints at the po­ten­tial for a glob­al eco­nom­ic down­turn. These mount­ing in­ter­na­tion­al ten­sions are once again chal­leng­ing the phar­ma­ceu­ti­cal sec­tor’s abil­i­ty to de­liv­er ther­a­pies con­sis­tent­ly and com­pli­ant­ly across bor­ders, de­mand­ing un­prece­dent­ed re­silience and adapt­abil­i­ty from every sup­ply chain stake­hold­er

In this en­vi­ron­ment, trust­ed part­ners stand apart by their abil­i­ty to an­tic­i­pate dis­rup­tion, adapt in re­al time, and main­tain con­ti­nu­ity. Whether rerout­ing ship­ments around bor­der clo­sures or ac­ti­vat­ing con­tin­gency pro­to­cols dur­ing a cri­sis, re­silience is not just about re­sponse, it’s about readi­ness. Pre­ci­sion lo­gis­tics providers have de­signed in­fra­struc­ture and pro­to­cols specif­i­cal­ly to with­stand volatil­i­ty, pow­ered by pre­dic­tive an­a­lyt­ics, AI-dri­ven route op­ti­miza­tion and decades of ex­pe­ri­ence man­ag­ing en­vi­ron­men­tal, po­lit­i­cal and op­er­a­tional chal­lenges.

5. Tech­no­log­i­cal in­no­va­tion & au­toma­tion

The fu­ture of bio­phar­ma lo­gis­tics is dig­i­tal and al­ready trans­form­ing the way crit­i­cal treat­ments move across the globe. From ware­house ro­bot­ics to AI-dri­ven fore­cast­ing, ma­chine learn­ing and route op­ti­miza­tion, tech­nol­o­gy is ac­cel­er­at­ing speed, ac­cu­ra­cy and con­trol across the sup­ply chain. Au­toma­tion, in­clud­ing ad­vanced stor­age and re­trieval sys­tems, stream­lines op­er­a­tions, re­duces the risk of hu­man er­ror and im­proves over­all ef­fi­cien­cy. In par­al­lel, ma­chine learn­ing and pre­dic­tive analy­sis en­able smarter, proac­tive de­ci­sion-mak­ing and en­hanced agili­ty – ca­pa­bil­i­ties that are mis­sion-crit­i­cal as ther­a­pies be­come more com­plex and per­son­al­ized.

This dig­i­tal in­fra­struc­ture helps pre­vent the in­fil­tra­tion of fake prod­ucts – an in­creas­ing threat un­der­scored by re­cent FDA warn­ings. Every Marken ship­ment is dig­i­tal­ly guard­ed, tracked, and pro­tect­ed, en­sur­ing coun­ter­feit prod­ucts do not in­fil­trate le­git­i­mate sup­ply chain chan­nels.

Nav­i­gat­ing the dis­tri­b­u­tion maze: From ori­gin to des­ti­na­tion

Every touch­point in the phar­ma­ceu­ti­cal jour­ney, from raw ma­te­r­i­al stor­age to last-mile de­liv­ery, de­mands metic­u­lous at­ten­tion and pre­ci­sion. Ef­fi­cient in­ven­to­ry man­age­ment, strict ad­her­ence to “First In, First Out” prin­ci­ples and val­i­dat­ed trans­porta­tion process­es en­sure that med­i­cines reach pa­tients safe­ly, time and with full com­pli­ance.

As per­son­al­ized med­i­cine and di­rect-to-pa­tient (DTP) mod­els be­come more preva­lent, lo­gis­tics part­ners must de­liv­er not on­ly op­er­a­tional ex­cel­lence, but al­so flex­i­ble, pa­tient-cen­tric so­lu­tions. Re­al-time track­ing sys­tems pro­vide full ship­ment vis­i­bil­i­ty, re­duc­ing er­rors, min­i­miz­ing stock­outs and en­sur­ing time­ly de­liv­ery.

The fi­nal mile is just as cru­cial. Whether de­liv­er­ing to hos­pi­tals, phar­ma­cies, or pa­tients’ homes, Marken en­sures prop­er han­dling and en­vi­ron­men­tal con­trols re­main un­com­pro­mised, en­sur­ing the ship­ment ar­rives in op­ti­mal con­di­tion.

The sci­ence be­hind stor­age: En­sur­ing pre­cise con­di­tions

Ef­fec­tive phar­ma­ceu­ti­cal stor­age is a pre­cise sci­ence, re­quir­ing rig­or­ous en­vi­ron­men­tal con­trols to pro­tect the po­ten­cy and sta­bil­i­ty of tem­per­a­ture- and time-sen­si­tive med­i­c­i­nal prod­ucts.

Marken’s GMP-com­pli­ant de­pots are equipped with val­i­dat­ed re­al-time mon­i­tor­ing sys­tems, da­ta log­gers for a ful­ly au­ditable trail, and au­to­mat­ed alert pro­to­cols to de­tect and trig­ger alerts for any de­vi­a­tion. Spe­cial­ized in­fra­struc­ture ca­pa­bil­i­ties, in­clud­ing liq­uid ni­tro­gen cryo­genic sta­tions, in-house dry ice man­u­fac­tur­ing, sus­tain­able closed loop so­lu­tions, sec­ondary la­bel­ing and de­sign ser­vices and pack­ag­ing-ag­nos­tic net­work main­tain the re­quired ther­mal con­di­tions through­out stor­age and tran­sit. Ad­di­tion­al risks, such as hu­mid­i­ty and light ex­po­sure are mit­i­gat­ed through in­te­grat­ed de­hu­mid­i­fi­ca­tion sys­tems, con­trolled light­ing, and phase-change, opaque pack­ag­ing to pre­serve prod­uct in­tegri­ty un­der any con­di­tion.

Se­cu­ri­ty is para­mount. Marken’s fa­cil­i­ties fea­ture ad­vanced ac­cess con­trols sys­tems, cut­ting-edge sur­veil­lance and in­tru­sion de­tec­tion tech­nolo­gies, en­sur­ing the high­est lev­els of prod­uct se­cu­ri­ty, pa­tient safe­ty and trust across the sup­ply chain.

The pow­er of pre­ci­sion: Part­ner­ship is the ul­ti­mate ad­van­tage

As the in­dus­try con­tin­ues to rapid­ly ad­vance, fu­eled by break­throughs in bi­o­log­ics, cell and gene ther­a­pies, and dig­i­tal health, the de­mands on stor­age and dis­tri­b­u­tion will on­ly in­ten­si­fy. Pre­ci­sion lo­gis­tics part­ners will play an in­creas­ing­ly crit­i­cal role in en­sur­ing the in­tegri­ty, safe­ty, and ef­fi­ca­cy of life-sav­ing treat­ments world­wide.

In this dy­nam­ic en­vi­ron­ment, suc­cess hinges on more than main­tain­ing tem­per­a­ture. It de­mands proven ex­per­tise, ro­bust dig­i­tal in­fra­struc­ture, and the op­er­a­tional agili­ty to nav­i­gate glob­al reg­u­la­to­ry and op­er­a­tional com­plex­i­ties. Marken or­ches­trates every step of the sup­ply chain with the pre­ci­sion, qual­i­ty, and re­silience re­quired to pro­tect the world’s most crit­i­cal ship­ments. When every ship­ment counts and every minute mat­ters, trust­ed part­ner­ship makes all the dif­fer­ence.

About Marken:

Marken, UPS Health­care Pre­ci­sion Lo­gis­tics (for­mer­ly Marken, MNX & Po­lar Speed), the clin­i­cal and ad­vanced ther­a­py sub­sidiary of UPS Health­care, unites ex­per­tise across health­care and com­plex se­cure lo­gis­tics to dri­ve the suc­cess of our clients through in­no­va­tion. Op­er­at­ing in 220+ coun­tries and ter­ri­to­ries, our team of 4,000 ex­perts or­ches­trate over 6.6M ship­ments an­nu­al­ly at all tem­per­a­ture ranges across our har­mo­nized air, sea and ground net­work. With a ready-now pack­ag­ing cat­a­log and glob­al de­pot ma­trix, Marken over­comes the most com­plex and evolv­ing in­dus­try chal­lenges, mit­i­gat­ing risks to al­ways make it hap­pen. Marken of­fers a com­plete range of ser­vices that in­te­grates drug sup­ply, stor­age and dis­tri­b­u­tion, ad­vanced ther­a­py, ra­dio phar­ma lo­gis­tics, pa­tient-dri­ven ser­vices, lab­o­ra­to­ry lo­gis­tics, kit­ting so­lu­tions, and con­nect­ed med­ical de­vice man­age­ment.  By pri­or­i­tiz­ing qual­i­ty and putting pa­tients first, Marken en­sures time and tem­per­a­ture-crit­i­cal ship­ments reach those who need them most.

EX­PLORE MORE